abs434.txt	red	blood	cell	(rbc)	partitioning	is	important	in	determining	pharmacokineticand	pharmacodynamic	properties	of	a	compound		however	active	transport	acrossrbc	membranes	not	well	understood	particularly	without	transporter-relatedcell	membrane	proteomics	data	2	this	study	we	quantified	breast	cancerresistance	protein	(bcrp/bcrp)	and	mdr1/p-glycoprotein	(p-gp)	expressionin	rbcs	from	humans	monkeys	dogs	rats	mice	using	nanolc/ms/ms	andevaluated	their	effect	on	rbc	plasma	exposure	theirsubstrates	bcrp-specific	substrate	cpd-1	mdr1-specific	cpd-2	werecharacterized	caco-2	transwellÂ®	system	then	administered	to	bcrp	orp-gp	knockout	3	the	quantification	revealed	bcrp/bcrp	but	mdr1/p-gp	tobe	highly	expressed	mouse	indicatedbcrp/bcrp	pumps	out	lowering	its	thuspreventing	binding	intracellular	targets	result	was	supported	by	cpd-1and	inhibitor	ml753286	drug-drug	interaction	(ddi)	because	ofenhanced	into	after	inhibition	plasmaconcentration	changed	much	less	extent	with	genetic	or	chemical	bcrpalbeit	marked	concentration	increase	suggesting	ddi	4	thisfinding	fundamentally	meaningful	pharmacokinetics	ddistudies	substrates
